1.
Kawakami J, Morales A. Clinical significance of suboptimal hormonal levels in men with prostate cancer treated with LHRH agonists. CUAJ [Internet]. 2013 Apr. 16 [cited 2026 Apr. 22];7(3-4):e226-30. Available from: https://cuaj.ca/index.php/journal/article/view/540